Definitive Contract 36C24720C0027

Award Date 11/1/19
Potential Completion Date 5/1/25
Potential Value $2.5M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Decatur, GA 30033, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 8 of the Department of Veterans Affairs to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, valued at $97,397.08, is for HIV/HCV cost per test services and is not set aside. Roche Diagnostics holds multiple General Services Administration (GSA) schedule contracts for laboratory...
This is a federal contract award made by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $338,633.72 Firm Fixed Price contract is for Molecular Pathology Testing HIV HCV and is categorized under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule. The contract does not have...
This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $305,417.32 Firm Fixed Price Delivery Order is for the provision of HIV/HBV molecular pathology reagents, with a completion date of March 31, 2020. The contract was issued under Roche's...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The award is a delivery order under Roche's General Services Administration (GSA) Federal Supply Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). The award provides Roche's COBAS AMPLIPREP/COBAS TAQMAN HIV-1 Test Version 2, a viral load...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $429,523.25, is a Blanket Purchase Agreement (BPA) call for HCV/HIV cost per test services during Fiscal Year 2018. The contract has no set-aside designation and is under Roche's General Services...
This federal contract award is for HIV/HBB CPRR Testing services provided by Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The $426,840.89 firm fixed-price delivery order contract was awarded on October 1, 2017 and has a completion date of March 1, 2019. The contract is not set-aside and was awarded under Roche's General Services Administration (GSA) Schedule 66...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $199,928.52, is for the delivery of interim molecular HIV and HCV testing services through a 5-year Blanket Purchase Agreement (BPA) and an Indefinite Delivery Contract (IDC). These provide the VA with...
This is a federal contract award issued by the Veterans Integrated Service Network 4 (VISN 4), a division of the Department of Veterans Affairs (VA), to Roche Diagnostics Corporation. The contract is for the delivery of PCR HIV-1 and HCV reagents and supplies, valued at $382,404.45. It was awarded as a Firm Fixed Price Delivery Order against Roche's existing Critical Analyzers, Laboratory Schedule contract with the General Services Administration (GSA). This contract does not have a set-aside...
This federal contract award is for the delivery of HIV reagents to the Department of Veterans Affairs (VA) Veterans Health Administration. The $117,225.68 firm fixed-price contract was awarded to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, laboratory instruments, and related products and services. The contract was issued through the VA's Veterans Integrated Service Network 4 and is not designated as a set-aside. Roche Diagnostics holds multiple General...
This is a federal contract award by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $250,257.63 for HIV/HCV laboratory testing services. The contract has a period of performance through October 17, 2017 and is not a set-aside award. Roche Diagnostics has been...

This federal contract award, valued at $2,509,113.95, was made by the Department of Veterans Affairs' Veterans Integrated Service Network 7 to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The award is for a Definitive Contract with Firm Fixed Pricing to provide molecular HIV/PCR cost-per-test and equipment lease services.

The original solicitation, Solicitation Number 36C24720Q0003, was issued to acquire a single analyzer capable of running FDA-approved real-time polymerase chain reaction (PCR) tests for Chlamydia trachomatis/Neisseria gonorrhoeae and quantitative viral load for HIV-1. The contract has an ultimate completion date of May 1, 2025 and does not include a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, has provided similar critical care analyzers, reagents, test kits and associated laboratory equipment, supplies and services to various federal agencies through its GSA Schedule contracts and other contract vehicles.

Generated 2/1/25, 9:02 AM